BIOSCEPTRE UK LTD has a total of 26 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in Australia, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are CSL Behring Lengnau AG, SHASHOUA VICTOR E and CSL BEHRING RECOMBINANT FACILITY AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Brazil | 3 | |
#4 | United States | 3 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | Mexico | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Barden Julian Alexander | 10 |
#2 | Coombs Justin Taylor | 8 |
#3 | Barry Simon Charles | 8 |
#4 | Sadlon Timothy John | 7 |
#5 | Moghaddam Minoo J | 6 |
#6 | Gong Xiaojuan | 6 |
#7 | Foeng Jade Hui Yu | 4 |
#8 | Julian Alexander Barden | 4 |
#9 | Bandara Kanchana Veronika | 4 |
#10 | Mccoll Shaun Reuss | 4 |
Publication | Filing date | Title |
---|---|---|
WO2021019222A1 | P2x7 receptor targeted therapy | |
CA3099712A1 | Chimeric antigen receptors with modified linker domains and uses thereof | |
EP3528789A1 | Cytotoxic particles | |
EP3277726A1 | Pain treatment |